annual CFI:
-$30.54M-$62.54M(-195.44%)Summary
- As of today (May 18, 2025), ACAD annual cash flow from investing activities is -$30.54 million, with the most recent change of -$62.54 million (-195.44%) on December 31, 2024.
- During the last 3 years, ACAD annual CFI has risen by +$40.56 million (+57.05%).
- ACAD annual CFI is now -115.86% below its all-time high of $192.51 million, reached on December 31, 2020.
Performance
ACAD Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$124.05M-$246.20M(-201.55%)Summary
- As of today (May 18, 2025), ACAD quarterly cash flow from investing activities is -$124.05 million, with the most recent change of -$246.20 million (-201.55%) on March 31, 2025.
- Over the past year, ACAD quarterly CFI has dropped by -$110.01 million (-783.60%).
- ACAD quarterly CFI is now -164.44% below its all-time high of $192.52 million, reached on March 31, 2023.
Performance
ACAD quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$140.55M-$110.01M(-360.24%)Summary
- As of today (May 18, 2025), ACAD TTM cash flow from investing activities is -$140.55 million, with the most recent change of -$110.01 million (-360.24%) on March 31, 2025.
- Over the past year, ACAD TTM CFI has increased by +$34.01 million (+19.48%).
- ACAD TTM CFI is now -172.53% below its all-time high of $193.78 million, reached on March 31, 2021.
Performance
ACAD TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ACAD Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -195.4% | -783.6% | +19.5% |
| 3 y3 years | +57.0% | -194.4% | -578.6% |
| 5 y5 years | +81.6% | -519.0% | +11.6% |
ACAD Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -141.7% | +57.0% | -164.4% | +36.1% | -186.5% | +19.5% |
| 5 y | 5-year | -115.9% | +81.6% | -164.4% | +36.1% | -172.5% | +45.9% |
| alltime | all time | -115.9% | +88.3% | -164.4% | +40.7% | -172.5% | +48.8% |
ACAD Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$124.05M(-201.6%) | -$140.55M(+360.2%) |
| Dec 2024 | -$30.54M(-195.4%) | $122.15M(-248.1%) | -$30.54M(-80.0%) |
| Sep 2024 | - | -$82.46M(+46.7%) | -$153.03M(+319.6%) |
| Jun 2024 | - | -$56.19M(+300.3%) | -$36.47M(-79.1%) |
| Mar 2024 | - | -$14.04M(+3945.8%) | -$174.56M(-645.5%) |
| Dec 2023 | $32.00M(-56.3%) | -$347.00K(-101.0%) | $32.00M(+119.2%) |
| Sep 2023 | - | $34.11M(-117.6%) | $14.60M(-458.5%) |
| Jun 2023 | - | -$194.28M(-200.9%) | -$4.07M(-103.0%) |
| Mar 2023 | - | $192.52M(-1184.7%) | $134.41M(+83.5%) |
| Dec 2022 | $73.24M(-203.0%) | -$17.75M(-214.9%) | $73.24M(-54.9%) |
| Sep 2022 | - | $15.44M(-127.7%) | $162.54M(-1862.1%) |
| Jun 2022 | - | -$55.80M(-142.5%) | -$9.22M(-131.4%) |
| Mar 2022 | - | $131.34M(+83.6%) | $29.37M(-141.3%) |
| Dec 2021 | -$71.10M(-136.9%) | $71.55M(-145.8%) | -$71.10M(-72.6%) |
| Sep 2021 | - | -$156.32M(+808.5%) | -$259.61M(-622.3%) |
| Jun 2021 | - | -$17.21M(-155.7%) | $49.71M(-74.3%) |
| Mar 2021 | - | $30.88M(-126.4%) | $193.78M(+0.7%) |
| Dec 2020 | $192.51M(-216.1%) | -$116.96M(-176.4%) | $192.51M(+91.9%) |
| Sep 2020 | - | $152.99M(+20.6%) | $100.32M(-334.7%) |
| Jun 2020 | - | $126.86M(+328.5%) | -$42.75M(-73.1%) |
| Mar 2020 | - | $29.61M(-114.2%) | -$158.99M(-4.1%) |
| Dec 2019 | -$165.84M(+132.0%) | -$209.14M(-2207.7%) | -$165.84M(+13.9%) |
| Sep 2019 | - | $9.92M(-6.6%) | -$145.64M(+17.7%) |
| Jun 2019 | - | $10.63M(-53.3%) | -$123.78M(-10.5%) |
| Mar 2019 | - | $22.76M(-112.0%) | -$138.35M(+93.5%) |
| Dec 2018 | -$71.49M(-177.3%) | -$188.95M(-694.5%) | -$71.49M(-171.9%) |
| Sep 2018 | - | $31.78M(-906.3%) | $99.37M(+14.3%) |
| Jun 2018 | - | -$3.94M(-104.4%) | $86.92M(-32.7%) |
| Mar 2018 | - | $89.62M(-595.3%) | $129.16M(+39.7%) |
| Dec 2017 | $92.47M(-135.3%) | -$18.09M(-193.6%) | $92.47M(-48.5%) |
| Sep 2017 | - | $19.33M(-49.5%) | $179.71M(+3187.7%) |
| Jun 2017 | - | $38.30M(-27.6%) | $5.47M(-113.6%) |
| Mar 2017 | - | $52.94M(-23.4%) | -$40.29M(-84.6%) |
| Dec 2016 | -$261.92M(-277.5%) | $69.14M(-144.6%) | -$261.92M(-4.5%) |
| Sep 2016 | - | -$154.91M(+1976.5%) | -$274.34M(+146.9%) |
| Jun 2016 | - | -$7.46M(-95.6%) | -$111.12M(+86.5%) |
| Mar 2016 | - | -$168.70M(-397.4%) | -$59.60M(-140.4%) |
| Dec 2015 | $147.57M(-269.1%) | $56.73M(+582.8%) | $147.57M(+12.4%) |
| Sep 2015 | - | $8.31M(-81.1%) | $131.32M(-18.9%) |
| Jun 2015 | - | $44.06M(+14.5%) | $161.89M(+221.8%) |
| Mar 2015 | - | $38.47M(-4.9%) | $50.31M(-157.6%) |
| Dec 2014 | -$87.27M | $40.48M(+4.1%) | -$87.27M(-26.2%) |
| Sep 2014 | - | $38.87M(-157.6%) | -$118.21M(-26.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$67.51M(-31.9%) | -$161.02M(-16.2%) |
| Mar 2014 | - | -$99.11M(-1138.8%) | -$192.13M(+52.4%) |
| Dec 2013 | -$126.10M(+394.0%) | $9.54M(-342.0%) | -$126.10M(-26.1%) |
| Sep 2013 | - | -$3.94M(-96.0%) | -$170.70M(+0.7%) |
| Jun 2013 | - | -$98.62M(+198.1%) | -$169.50M(+171.2%) |
| Mar 2013 | - | -$33.09M(-5.6%) | -$62.49M(+144.8%) |
| Dec 2012 | -$25.53M(-526.9%) | -$35.05M(+1177.5%) | -$25.53M(-291.3%) |
| Sep 2012 | - | -$2.74M(-132.7%) | $13.34M(-35.1%) |
| Jun 2012 | - | $8.39M(+116.5%) | $20.56M(+10.6%) |
| Mar 2012 | - | $3.88M(+1.6%) | $18.59M(+210.9%) |
| Dec 2011 | $5.98M(-664.2%) | $3.81M(-14.8%) | $5.98M(-206.9%) |
| Sep 2011 | - | $4.48M(-30.3%) | -$5.60M(-21.5%) |
| Jun 2011 | - | $6.42M(-173.5%) | -$7.13M(-56.3%) |
| Mar 2011 | - | -$8.73M(+12.5%) | -$16.31M(+1439.1%) |
| Dec 2010 | -$1.06M(-111.2%) | -$7.76M(-363.7%) | -$1.06M(-107.0%) |
| Sep 2010 | - | $2.94M(-206.6%) | $15.23M(-33.3%) |
| Jun 2010 | - | -$2.76M(-142.4%) | $22.82M(+378.0%) |
| Mar 2010 | - | $6.52M(-23.6%) | $4.77M(-49.5%) |
| Dec 2009 | $9.44M(-86.5%) | $8.53M(-19.0%) | $9.44M(-24.1%) |
| Sep 2009 | - | $10.53M(-150.6%) | $12.45M(-38.0%) |
| Jun 2009 | - | -$20.80M(-285.9%) | $20.09M(-64.3%) |
| Mar 2009 | - | $11.19M(-3.0%) | $56.27M(-19.3%) |
| Dec 2008 | $69.71M(-266.4%) | $11.53M(-36.5%) | $69.71M(+6.7%) |
| Sep 2008 | - | $18.17M(+18.2%) | $65.35M(+48.0%) |
| Jun 2008 | - | $15.38M(-37.6%) | $44.17M(-218.6%) |
| Mar 2008 | - | $24.64M(+243.4%) | -$37.24M(-11.1%) |
| Dec 2007 | -$41.90M(+82.7%) | $7.17M(-337.7%) | -$41.90M(-12.9%) |
| Sep 2007 | - | -$3.02M(-95.4%) | -$48.11M(+5.5%) |
| Jun 2007 | - | -$66.03M(-430.6%) | -$45.62M(+1178.2%) |
| Mar 2007 | - | $19.97M(+1965.3%) | -$3.57M(-84.4%) |
| Dec 2006 | -$22.94M(+244.9%) | $967.00K(-283.1%) | -$22.94M(+27.8%) |
| Sep 2006 | - | -$528.00K(-97.8%) | -$17.95M(+349.7%) |
| Jun 2006 | - | -$23.98M(-4070.0%) | -$3.99M(+27.2%) |
| Mar 2006 | - | $604.00K(-89.8%) | -$3.14M(-52.8%) |
| Dec 2005 | -$6.65M(-9.9%) | $5.95M(-55.7%) | -$6.65M(+122.2%) |
| Sep 2005 | - | $13.43M(-158.1%) | -$2.99M(-77.6%) |
| Jun 2005 | - | -$23.13M(+695.3%) | -$13.34M(+2.3%) |
| Mar 2005 | - | -$2.91M(-130.3%) | -$13.04M(+76.7%) |
| Dec 2004 | -$7.38M(-49.8%) | $9.61M(+211.0%) | -$7.38M(-56.6%) |
| Sep 2004 | - | $3.09M(-113.5%) | -$16.99M(-15.4%) |
| Jun 2004 | - | -$22.83M(-930.0%) | -$20.08M(-830.0%) |
| Mar 2004 | - | $2.75M | $2.75M |
| Dec 2003 | -$14.69M(-481.7%) | - | - |
| Dec 2002 | $3.85M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual CFI year-on-year change?
- What is ACADIA Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly CFI year-on-year change?
- What is ACADIA Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM CFI year-on-year change?
What is ACADIA Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ACAD is -$30.54M
What is the all time high annual CFI for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual cash flow from investing activities is $192.51M
What is ACADIA Pharmaceuticals annual CFI year-on-year change?
Over the past year, ACAD annual cash flow from investing activities has changed by -$62.54M (-195.44%)
What is ACADIA Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ACAD is -$124.05M
What is the all time high quarterly CFI for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly cash flow from investing activities is $192.52M
What is ACADIA Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ACAD quarterly cash flow from investing activities has changed by -$110.01M (-783.60%)
What is ACADIA Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ACAD is -$140.55M
What is the all time high TTM CFI for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM cash flow from investing activities is $193.78M
What is ACADIA Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ACAD TTM cash flow from investing activities has changed by +$34.01M (+19.48%)